Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment
- First Posted Date
- 2014-09-19
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 48
- Registration Number
- NCT02244827
- Locations
- 🇺🇸
University of Miami,Division of Clinical Pharmacology, Miami, Florida, United States
Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-08-15
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 80
- Registration Number
- NCT02217930
- Locations
- 🇺🇸
Phase 1 unit : Spaulding Clinical Research, LLC, West Bend, Wisconsin, United States
Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers
- First Posted Date
- 2013-06-12
- Last Posted Date
- 2013-08-22
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 12
- Registration Number
- NCT01875939
- Locations
- 🇺🇸
PPD Phase I unit, 7551 Metro Center Drive, Suite 200, Austin, Texas, United States
Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Listro Mix 50/50® and Humalog Mix50/50® in Healthy Subjects
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Wockhardt
- Registration Number
- NCT01400789
- Locations
- 🇺🇸
Profil Institute for Clinical Research, Inc., San Diego, California, United States
Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Wockhardt
- Registration Number
- NCT01400802
- Locations
- 🇺🇸
Profil Institute for Clinical Research, Inc., San Diego, California, United States
Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects
- First Posted Date
- 2011-07-21
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Wockhardt
- Registration Number
- NCT01399255
- Locations
- 🇺🇸
Profil Institute for Clinical Research, Inc., Chula Vista, California, United States
Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics
- First Posted Date
- 2011-07-20
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Wockhardt
- Registration Number
- NCT01398670
Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-05-23
- Last Posted Date
- 2012-12-27
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 53
- Registration Number
- NCT01358435
- Locations
- 🇺🇸
Profil Institute for Clinical Research, Chula Vista, California, United States
Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM
- First Posted Date
- 2011-05-20
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 111
- Registration Number
- NCT01357603
- Locations
- 🇺🇸
Profil Institute for clinical Research, Chula Vista, California, United States
Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients
Phase 3
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2011-05-12
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Wockhardt
- Registration Number
- NCT01352663
© Copyright 2024. All Rights Reserved by MedPath